Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11746176.4Aexternal-prioritypatent/EP2600838B1/en
Application filed by Grünenthal GmbHfiledCriticalGrünenthal GmbH
Publication of CY1116996T1publicationCriticalpatent/CY1116996T1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Η εφεύρεση σχετίζεται με μια φαρμακευτική δοσολογική μορφή για χορήγηση δύο φορές την ημέρα, μια φορά την ημέρα ή λιγότερο συχνά, που περιέχει 6'-φθορο-(Ν-μεθυλο- ή Ν,Ν-διμεθυλο-)-4-φαινυλο-4',9'-διυδρο-3'Η-σπιρο[κυκλοεξαν-1,1'-πυρανο[3,4-β]ινδολ]-4-αμίνη ή ένα φυσιολογικώς αποδεκτό άλας αυτής.The invention relates to a pharmaceutical dosage form for administration twice daily, once daily or less frequently, containing 6'-fluoro- (N-methyl- or N, N-dimethyl-) -4-phenyl-4 ' , 9'-dihydro-3'H-spiro [cyclohexane-1,1'-pyrano [3,4-b] indole] -4-amine or a physiologically acceptable salt thereof.
Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
Pharmaceutical dosage aid comprising 6´fluoro- (n-methyl-o n, n.dimethyl) -4-phenyl-4´9-dhydro-3 h spiro [cyclohexan-1´1-pyrano [3.4, b [indole ] -4-amine
Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1 '-pyrano[3,4,b]indol]-4-amine for the treatment of neuropathic pain.
PHARMACEUTICAL FORM DOSAGE WHICH INCLUDES 6'-Fluoro- (N-METHYL- Ή N, N-DIMETHYL-) - 4-PHENYL-4 ', 9'-DIHYDRO-3'H-SP1 PYRANO [3,4, Β] INDOL] -4-AMINE FOR THE TREATMENT OF NEUROPATHY PAIN
(1R, 4R) -6'-Fluoro- (N-Methyl-N, N-Dimethyl -) - 4-phenyl-4 ', 9'-dihydro-3'H-spiro- [CYCLOEXANO-1,1' PYRANO [3,4, B] INDOL] -4-AMINE FOR TREATMENT OF FIOMOYLGY AND YOUNG COUPE SYNDROME